Narayana Hrudayalaya Limited (NSE:NH)
India
· Delayed Price · Currency is INR 1,694.30
+20.90 (1.25%)
Mar 28, 2025, 3:30 PM IST
Narayana Hrudayalaya Revenue
Narayana Hrudayalaya had revenue of 13.67B INR in the quarter ending December 31, 2024, with 13.55% growth. This brings the company's revenue in the last twelve months to 53.84B, up 8.35% year-over-year. In the fiscal year ending March 31, 2024, Narayana Hrudayalaya had annual revenue of 50.18B with 10.79% growth.
Revenue (ttm)
53.84B
Revenue Growth
+8.35%
P/S Ratio
6.38
Revenue / Employee
4.62M
Employees
11,659
Market Cap
343.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 50.18B | 4.89B | 10.79% |
| Mar 31, 2023 | 45.30B | 8.28B | 22.38% |
| Mar 31, 2022 | 37.01B | 11.17B | 43.24% |
| Mar 31, 2021 | 25.84B | -5.53B | -17.62% |
| Mar 31, 2020 | 31.36B | 2.62B | 9.13% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
Narayana Hrudayalaya News
- 23 days ago - Narayana Hrudayalaya’s subsidiary HCCI enters joint venture for cancer care in India - Business Upturn
- 5 weeks ago - Stocks to watch today on 21 Feb: Cipla, Senores, Narayana Hrudayalaya, Sanofi in pharmaceuticals and healthcare sector - Business Upturn
- 5 weeks ago - Narayana Hrudayalaya Ltd (NSE:NH) Q3 2025 Earnings Report Preview: What To Look For - GuruFocus
- 6 weeks ago - Key Results Today: Glenmark Pharma, ABFRL, GNFC, and Narayana Hrudayalaya among stocks in focus as Q3 results roll in - Business Upturn
- 7 weeks ago - Narayana Hrudayalaya shares surge 3% after lLand acquisition in South Bengaluru - Business Upturn
- 7 weeks ago - Narayana Hrudayalaya expands footprint with new land purchase in Bengaluru - Business Upturn
- 3 months ago - Zaggle Prepaid Ocean Services collaborates with Narayana Hrudayalaya for employee expense management solutions - Business Upturn
- 5 months ago - Stocks in focus: Tata Invest, Narayana Hrudayalaya, BF Utilities, Sudarshan Pharma and others set to announce Q2 FY24-25 results today - Business Upturn